Publications
- Treatment of consecutive patients with chronic myeloid leukaemia in the cooperating centres from the Czech Republic and the whole of Slovakia after 2000 - a report from the population-based CAMELIA registry2011 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University
- Dasatinib in imatinib-resistant or -intolerant CML patients: data from the clinical practice of 6 hematological centers in the Czech Republic2010 | Faculty of Medicine in Hradec Králové, Faculty of Physical Education and Sport
- Treatment of chronic myeloid leukemia in adults in 20102010 | Faculty of Medicine in Hradec Králové
- Treatment decisions in chronic myeloid leukemia in the view of BCR-ABL1 mutations in practice2010 | Faculty of Medicine in Hradec Králové
- Imatinib mesylate efficacy in 72 previously treated Philadelphia-positive chronic myeloid leukemia patients with and without additional chromosomal changes: single-center results +12009 | Publication without faculty affiliation
- Comments to the study Dasatinib 140 mg once daily vs dasatinib 70 mg bid in patients with CML in accelerated phase +12009 | Publication without faculty affiliation
- Chronic myeloid leukemia +22009 | Publication without faculty affiliation
- Imatinib resistance in CML treatment +12008 | Publication without faculty affiliation
- Plasma levels of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (BGFG) and soluble endoglin (SCD105) in patients with chronic myeloid leukemia: impact of treatment with imatinib mesylate +1Publication without faculty affiliation
- De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors2024 | Faculty of Medicine in Hradec Králové, Central Library of Charles University, Faculty of Medicine in Pilsen
Loading network view...